Products

What will AGI do for Abecarnil?

This classification denotes an anxiolytic with the molecular formula C24H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IZM1PNJ3JL, chemically known as 9h-pyrido(3,4-b)indole-3-carboxylic acid, 1-(methoxymethyl)-6-(phenylmethoxy)-, 1-methylethyl ester but generally known as abecarnil, which bears US NIH Compound Identifier 65914. European Medicines Agency schedules Abecarnil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07360MIG. The term ABECARNIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). ABECARNIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule abecarnil under HS 29339990 and SITC 51577. As of Q4 2014, ABECARNIL remains the US FDA Preferred Term for this commodity. Abecarnil bears US NLM identifiers UMLS ID C0050360 and NCI Concept Code C76501. SMILES: O(C1CC2C3C([NH]C2CC1)CNC(C3COC)C(=O)OC(C)C)CC1CCCCC1.

How AGI delivers it

Four ways AGI delivers for Abecarnil

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Abecarnil, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Abecarnil, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Abecarnil connects

measured by

  • Active Ingredient Assaymodel
  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Particle Size Distributionmodel
  • Residual Solventmodel